Multiple primary cancers of the ovary in the United States, 1992-1997

Cancer

Volumn 97, Issue 10 SUPPL., 2003, Pages 2660-2675

  Howe, Holly L ^a   Weinstein, Rachel ^b   Hotes, Joellyn ^a   Kohler, Betsy ^b   Roffers, Steven D ^c   Goodman, Marc T ^d  

^a N Amer Assoc Ctrl Cancer Regis   (United States)

^b New Jersey State Cancer Registry   (United States)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CAUCASIAN; CHILD; CLEAR CELL CARCINOMA; ENDOMETRIOID CARCINOMA; ETHNOLOGY; FEMALE; GERM CELL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; NEWBORN; OVARY CANCER; PRIORITY JOURNAL; RACE DIFFERENCE; SEX CORD TUMOR; UNITED STATES;

EID: 0037629064     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11348     Document Type: Article

References (26)

1. Billroth CAT. Die allgemeine chirurgische pathologie und therapie. Berlin: G. Reimer, 1889:908.
2. Warren S, Gates O. Multiple primary malignant tumors: a survey of the literature and statistical study. Am J Cancer. 1932;1358-1414.
3. Moertel CB, Dockerty MB, Baggenstoss AH. Multiple primary malignant neoplasms. I. Introduction and presentation of data. II. Tumors of different tissues or organs. Cancer. 1961;14:221-237.
4. Schottenfeld D. Multiple primary cancers. In: Schottenfeld D, Fraumeni JF, editors. Cancer epidemiology and prevention. New York: Oxford University Press, 1996:1370-1387.
5. Auranen S-AK, Grénman SK, Mäkinen JI, Salmi TA. Primary breast and colon cancer associated with endometrial or ovarian cancer. Ann Chir Gynaecol Suppl. 1994;83:5-9.
6. Fishman A, Dekel E, Chetrit A, et al. Patients with double primary tumors in the breast and ovary. Clinical characteristics and BRCA1-2 mutations status. Gynecol Oncol. 2000; 29:74-78.
7. Sheu B-C, Lin H-H, Chen C-K, Chao K-H, Shun C-T, Huang S-C. Synchronous primary carcinomas of the endometrium and ovary. Int J Gynecol Obstet. 1995;51:141-146.
8. McGuire V, Whittemore AS, Norris R, Oakley-Girvan I. Survival in epithelial ovarian cancer patients with prior breast cancer. Am J Epidemiol. 2000;152:528-532.
9. Suris-Swartz PJ, Schildkraut JM, Vine MF, Hertz-Picciotto I. Age at diagnosis and multiple primary cancers of the breast and ovary. Breast Cancer Res Treat. 1996;41:21-29.
10. Fritz A, Ries L, editors. SEER program code manual, 3rd edition. Bethesda: National Cancer Institute, 1998.
11. Lee TK, Myers RT, Scharyj M, Marshall RB. Multiple primary malignant tumors: study of 68 autopsy cases (1963-1980). J Am Geriatr Soc. 1982;30:744-753.
12. Boice JD Jr., Curtis RE, Kleinerman RA, Flannery JT, Fraumeni JF Jr. Multiple primary cancers in Connecticut, 1935-1982. Yale J Biol Med. 1986;59:533-545.
13. Ries LAG, Eisner MP, Kosary CL, et al., editors. SEER cancer statistics review, 1973-1998 [monograph online]. Bethesda: National Cancer Institute, 2001. Available from URL: http://seer.cancer.gov/Publications/CSR1973_1998/(accessed 21 March 2003).
14. Fishman A, Aviram R, Beyth Y, Bernheim J, Altaras M. A second primary malignancy in a cohort of patients with epithelial ovarian cancer - characteristics of diagnosis. Eur J Gynaecol Oncol. 1998;19:280-283.
15. Bergfeldt K, Silfverswärd C, Einhorn S, Hall P. Overestimated risk of second primary malignancies in ovarian cancer patients. Eur J Cancer. 2000;36:100-105.
16. Sagawa T, Yamashita Y, Fujimoto T, et al. Clinicopathological comparisons of familial and sporadic cases in 219 consecutive Japanese epithelial ovarian cancer patients. Jpn J Clin Oncol. 1999;29:556-561.
17. Chu CS, Morgan MA, Randall TC, Bandera CA, Rubin SC. Survival of BRCA1 negative ovarian cancer patients based on family history. Gynecol Oncol. 2001;83:109-114.
18. Rubin SC, Benjamin I, Behbakht K, et al. Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med. 1996;335:1413-1416.
19. Narod SA, Boyd J. Current understanding of the epidemiology and clinical implications of BRCA1 and BRCA2 mutations for ovarian cancer. Curr Opin Obstet Gynecol. 2002;14: 19-26.
20. Dent SF, Klaasen D, Pater JL, Zee B, Whitehead M. Second primary malignancies following the treatment of early stage ovarian cancer: update of a study by the National Cancer Institute of Canada - Clinical Trials Group. Ann Oncol. 2000; 11:65-68.
21. Goodman MT, Howe HL. Descriptive epidemiology of ovarian cancer in the United States, 1992-1997. Cancer. 2003; 97(10 Suppl):2615-2630.
22. Travis LB, Holowaty EJ, Bergfeldt K, et al. Risk of leukemia after platinum-based chemotherapy for ovarian cancer. N Engl J Med. 1999;340:351-357.
23. Castro IM, Connell PP, Wagoner S, Robmensch J, Mundt AJ. Synchronous ovarian and endometrial malignancies. Am J Clin Oncol. 2000;23:521-525.
24. Kehoe S, Powell JE. Prior, synchronous and secondary malignancies in women with ovarian cancer. Int J Gynecol Obstet. 2001;73:265-267.
25. Anderson H, Badström A, Olsson H, Möller TR. Familial breast and ovarian cancer: a Swedish population-based register study. Am J Epidemiol. 2000;152:1154-1163.
26. Muir CS, Percy C. Classification and coding of neoplasms. In: Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG, editors. Cancer registration: principles and methods. Lyon: IARC Press, 1991:78-79.